Skip to main content

Market Overview

BMO Capital Markets Reiterates Underperform Rating, $30 PT on Zoetis on Avian Flu Scare

Share:

In a report published Friday, BMO Capital Markets analyst Alex Arfaei reiterated an Underperform rating and $30.00 price target on Zoetis (NYSE: ZTS).

In the report, Arfaei noted, “Shares of Zoetis are weak today in part related to the 14 human cases of the H7N9 virus, an unusual strain of bird flu that has so far killed six people in China, which has in turn led the Chinese authorities to kill more than 20,000 birds from a live-poultry trading zone. Shanghai will temporarily close all its live poultry markets starting Saturday.”

Zoetis closed on Thursday at $31.84.

Latest Ratings for ZTS

DateFirmActionFromTo
Mar 2021Raymond JamesUpgradesMarket PerformOutperform
Mar 2021B of A SecuritiesUpgradesNeutralBuy
Feb 2021Credit SuisseMaintainsOutperform

View More Analyst Ratings for ZTS
View the Latest Analyst Ratings

 

Related Articles (ZTS)

View Comments and Join the Discussion!

Posted-In: BMO Capital MarketsAnalyst Color Reiteration Analyst Ratings

Latest Ratings

StockFirmActionPT
GOOGLMizuhoMaintains2,600.0
VZIOWells FargoInitiates Coverage On31.0
TWTROppenheimerMaintains85.0
SBUXOppenheimerMaintains135.0
OMWells FargoInitiates Coverage On63.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com